INSR and endothelial dysfunction: Inhibition of PTP has been shown to attenuate endothelial dysfunction via upregulation of eNOS in the mouse model of chronic heart failure [35] and treatment with the nonselective PTP inhibitors such as vanadate and BMOV-enhanced insulin receptor activation and restored insulin signaling in diabetic rats [36–38].